Carbon Dye Tattooing of Biopsied Axillary Node in Breast Cancer (pre-ATNEC)
Pre-ATNEC - A Multicentre Prospective Feasibility Study of Carbon Dye Tattooing of Biopsied Axillary Node and Surgical Localisation in Breast Cancer Patients
Sponsor: University Hospitals of Derby and Burton NHS Foundation Trust
A NA clinical study on Axilla; Breast and Breast Cancer, this trial is completed. The trial is conducted by University Hospitals of Derby and Burton NHS Foundation Trust and has accumulated 10 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Nov 2020 — Jan 2021 [monthly]
Completed NA
-
Aug 2020 — Nov 2020 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Jun 2020 — Aug 2020 [monthly]
Completed NA
-
Feb 2020 — Jun 2020 [monthly]
Completed NA
-
Sep 2019 — Feb 2020 [monthly]
Completed NA
Status: Recruiting → Completed
-
Nov 2018 — Sep 2019 [monthly]
Recruiting NA
-
Sep 2018 — Nov 2018 [monthly]
Recruiting NA
First recorded
Apr 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospitals of Derby and Burton NHS Foundation Trust
For direct contact, visit the study record on ClinicalTrials.gov .